Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced that its stability storage division, Q1 Scientific, has opened a new cGMP facility in Durham, North Carolina, expanding its capacity to provide environmentally controlled stability storage services for the pharmaceutical industry , medical device and life sciences industries expanded in North America.
The new state-of-the-art temperature-controlled and monitored storage facility is strategically located in the Research Triangle Park region and features 7 ICH stability chambers covering a range of conditions including 2-8°C, 25°C/60% RH, 30°C/ 65% RH, 30°C/75% RH and 40°C/75% RH, as well as -20°C and extra low temperature storage conditions (-70°C/-80°C). The Research Triangle Park (RTP) office in North Carolina will offer same-day and next-day delivery throughout the United States.
Tom Loewald, CEO of Cambrex, stated: “Following the acquisition of Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our customers worldwide. The opening of this first North American facility is an important milestone in the growth of Q1 Scientific.”
The Q1 Scientific expansion complements existing facilities in Waterford, Ireland and Liège, Belgium and is linked to Cambrex’s existing analytical services site in Durham.
Stephen Delaney, managing director of Q1 Scientific, added: “With the skills and expertise we have brought together in Durham, we can now offer services beyond stability storage, such as: B. Stability testing and other analytical services for clinical and commercial products.”
Cambrex continues to expand its capabilities and capacity across its North American and European network to meet growing demand for outsourced drug development and manufacturing services.
Information about Cambrex
Cambrex is a leading global contract development and manufacturing organization (CDMO), providing lifecycle drug development and manufacturing as well as comprehensive analytical and IND-related services.
With more than 40 years of experience and a team of 2,000 professionals serving global customers in North America and Europe, Cambrex offers a range of specialized drug discovery technologies and capabilities, including continuous flow, controlled substances, solid state research, materials characterization and highly active APIs.
About Q1 Scientific, a Cambrex company
Q1 Scientific, a Cambrex company, is a leading provider of environmentally controlled stability storage services to the pharmaceutical, medical device and life sciences industries. With a decade of experience, Q1 Scientific secures critical breakthroughs and life-changing innovations in state-of-the-art facilities in Ireland and Belgium. Q1 Scientific provides companies with services that help them speed new medicines to market while avoiding the costs of building and monitoring their own storage rooms. In June 2022, Q1 Scientific was acquired by Cambrex.
Logo – https://mma.prnewswire.com/media/2236065/Cambrex_logo.jpg
Logo – https://mma.prnewswire.com/media/1830431/Q1_Scientific_Cambrex_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/cambrex-eroffnet-neue-stabilitatslagereinrichtung-in-durham-north-carolina-302279711.html